Cancer Testis Antigen (CTA) T21, as a Potential Diagnostic, Prognostic, and Immune-Therapeutic Targets for Malignant Tumours. (H. M. . Tawel, Y. M. A. . Hasen, & A. . Miles, Trans.). (2022). Journal of Medical Sciences, 17(1), 1-7. https://doi.org/10.51984/joms.v17i1.1892